Islet Holdings, Inc.
ISHI
Other OTC0.00
USD
- -
- -
ISIN
US46467L1026
CUSIP
46467L102
Return %
Stock
S&P500
1Y
0.00
26.57
3Y
-50.00
76.60
5Y
-99.83
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- J. Michael Heil
- Full Time Employees
- 7
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 11884 Tammy Way Grass Valley CA United States of America 95949
- IPO Date
- Mar 23, 2012
- Website
- revitacell.com
- Similar Companies
- Business
- Islet Holdings, Inc. (ISHI) develops, markets and distributes skincare and cosmeceutical products primarily in the United States through online channels and a multilevel distributor network. The company offers a comprehensive range of core products including acne-prone skin treatments; anti-aging formulations; Berridroxies; botanical-based solutions; eye treatments; moisturizers and creams; sensitive skin products; toners and cleansers; and specialized skincare items under the RevitaCell brand, while also distributing products from various third-party brands. Founded in 1984 and headquartered at 11884 Tammy Way, Grass Valley, California, with a customer service center in Arizona, Islet Holdings operates in the personal care products segment of the household sector, targeting consumers seeking targeted skincare solutions for various skin types and concerns. Formerly known as Biozhem Cosmeceuticals, Inc., the company changed its name to Islet Holdings, Inc. in May 2009 to reflect its expanded focus; no major acquisitions, funding rounds, partnerships, new product launches or strategic expansions have been reported in the last one to two years.